PropertyValue
?:abstract
  • Thrombotic complications and coagulopathy frequently occur in COVID-19. However, the characteristics of COVID-19-associated coagulopathy (CAC) are distinct from those seen with bacterial sepsis-induced coagulopathy (SIC) and disseminated intravascular coagulation (DIC), with CAC usually showing increased D-dimer and fibrinogen levels but initially minimal abnormalities in prothrombin time and platelet count. Venous thromboembolism and arterial thrombosis are more frequent in CAC compared to SIC/DIC. Clinical and laboratory features of CAC overlap somewhat with a hemophagocytic syndrome, antiphospholipid syndrome, and thrombotic microangiopathy. We summarize the key characteristics of representative coagulopathies, discussing similarities and differences so as to define the unique character of CAC.
?:creator
?:doi
  • 10.1186/s13054-020-03077-0
?:doi
?:journal
  • Crit_Care
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/0159d3e7cfc3e78a2bd6429991d043a89764fc85.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7301352.xml.json
?:pmcid
?:pmid
?:pmid
  • 32552865.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • The unique characteristics of COVID-19 coagulopathy
?:type
?:year
  • 2020-06-18

Metadata

Anon_0  
expand all